Position in MYGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$8,702
+$791 QoQ
Shares Held
1,524
-13.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#156
of 197 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Physician Wealth Advisors, Inc. holds $574,032 across 26 Diagnostics & Research names. MYGN ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
548 | $274,745 | |
| 2 | DHR |
Danaher Corp /De/
|
451 | $85,906 | |
| 3 | WAT |
Waters Corp /De/
|
193 | $72,382 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 5 | A |
Agilent Technologies, Inc.
|
133 | $17,666 | |
| 6 | GH |
Guardant Health, Inc.
|
101 | $15,153 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
43 | $9,751 | |
| 8 | MYGN |
Myriad Genetics Inc
This page
|
1,524 | $8,702 |
All Filings in MYGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,702 | 1,524 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,911 | 1,758 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $9,372 | 1,524 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $11,018 | 1,524 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,092 | 1,524 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $13,517 | 1,524 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $20,894 | 1,524 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||